Yang YJ - Search Results

1

Comparison of the prevalence, clinical features, and long-term outcomes of midventricular hypertrophy vs apical phenotype in patients with hypertrophic cardiomyopathy.

Cai C, Duan FJ, Yang YJ, Guo XY, Liu YL, Liu YQ, Yan LR, Xu ZM, Zhao SH, Hua W, Li YS, Fan CM. Cai C, et al. Among authors: yang yj. Can J Cardiol. 2014 Apr;30(4):441-7. doi: 10.1016/j.cjca.2013.10.005. Epub 2013 Oct 9. Can J Cardiol. 2014. PMID: 24468417

2

[The clinical and social implications of mutation detection in patients with hypertrophic cardiomyopathy].

Yang YJ, Fan CM. Yang YJ, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Aug;41(8):716-8. Zhonghua Xin Xue Guan Bing Za Zhi. 2013. PMID: 24225248 Review. Chinese. No abstract available.

3

Clinical characteristics and prognosis of 60 patients with midventricular obstructive hypertrophic cardiomyopathy.

Yan LR, Zhao SH, Wang HY, Duan FJ, Wang ZM, Yang YJ, Guo XY, Cai C, Xu ZM, Li YS, Fan CM. Yan LR, et al. Among authors: yang yj. J Cardiovasc Med (Hagerstown). 2015 Nov;16(11):751-60. doi: 10.2459/JCM.0000000000000163. J Cardiovasc Med (Hagerstown). 2015. PMID: 25022933

4

Survival after alcohol septal ablation versus conservative therapy in obstructive hypertrophic cardiomyopathy.

Yang YJ, Fan CM, Yuan JQ, Qiao SB, Hu FH, Guo XY, Li YS. Yang YJ, et al. Cardiol J. 2015;22(6):657-64. doi: 10.5603/CJ.a2015.0032. Epub 2015 Jun 23. Cardiol J. 2015. PMID: 26100829

5

Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy.

Yang YJ, Yuan JQ, Fan CM, Pu JL, Fang PH, Ma J, Guo XY, Li YS. Yang YJ, et al. Heart Vessels. 2016 Jul;31(7):1148-53. doi: 10.1007/s00380-015-0718-5. Epub 2015 Aug 1. Heart Vessels. 2016. PMID: 26231425

6

The Prevalence and Long-Term Outcomes of Extreme Right versus Extreme Left Ventricular Hypertrophic Cardiomyopathy.

Guo X, Fan C, Wang H, Zhao S, Duan F, Wang Z, Yan L, Yang Y, An S, Li Y. Guo X, et al. Cardiology. 2016;133(1):35-43. doi: 10.1159/000439345. Epub 2015 Sep 29. Cardiology. 2016. PMID: 26414322

7

[Clinical features and long-term outcome comparison of patients with midventricular obstructive hypertrophic cardiomyopathy and apical hypertrophic cardiomyopathy].

An S, Cai C, Duan F, Yang Y, Guo X, Liu Y, Liu Y, Yan L, Xu Z, Zhao S, Hua W, Fan C, Li Y. An S, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Oct;43(10):874-8. Zhonghua Xin Xue Guan Bing Za Zhi. 2015. PMID: 26652989 Chinese.

8

Effectiveness of Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy With Versus Without Extreme Septal Hypertrophy.

Yang YJ, Fan CM, Yuan JQ, Wang ZM, Duan FJ, Qiao SB, You SJ, Yuan JS, Hu FH, Yang WX, Guo XY, Li YS. Yang YJ, et al. Among authors: yang wx. J Invasive Cardiol. 2016 Mar;28(3):99-103. J Invasive Cardiol. 2016. PMID: 26945252 Free article.

9

Effectiveness of Alcohol Septal Ablation Versus Transaortic Extended Myectomy in Hypertrophic Cardiomyopathy with Midventricular Obstruction.

Yang YJ, Fan CM, Yuan JQ, Wang SY, Song YH, Qiao SB, You SJ, Wang ZM, Duan FJ, Li YS. Yang YJ, et al. J Interv Cardiol. 2016 Dec;29(6):619-627. doi: 10.1111/joic.12331. Epub 2016 Aug 22. J Interv Cardiol. 2016. PMID: 27545664 Free article.

10

Comparison of Long-Term Outcome between Apical and Asymmetric Septal Hypertrophic Cardiomyopathy.

An S, Fan C, Yan L, Cai C, Yang Y, Zhai S, Zhao S, Liu Y, Duan F, Wang Z, Li Y. An S, et al. Cardiology. 2017;136(2):108-114. doi: 10.1159/000448239. Epub 2016 Sep 6. Cardiology. 2017. PMID: 27595481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,412 results

Search Page

Filters